IMMUNODIAGNOSTIC SYSTEMS HOLDINGS PLC Immunodiagnostic Systems Holdings plc
Director Dealing
20 January 2017
Immunodiagnostic Systems Holdings plc (IDH.L) ('IDS' or the 'Company'), a specialist producer of manual and automated diagnostic testing kits and instrumentation for the clinical and research markets,was advised on 20 January that earlier today Till Campe, Non-Executive Director, acquired 1,800 ordinary shares of 2p each ('Ordinary Shares') in the Company at an average price of £2.49 per Ordinary Share.
Following these purchases, Mr Campe is interested in 3,590 Ordinary Shares, 0.01% of the issued share capital of the Company.
For further information:
Immunodiagnostic Systems Holdings plc | Tel : +44 (0)191 519 0660 |
Patricio Lacalle, Chief Executive Officer | |
Paul Martin, Group Finance Director | |
Peel Hunt LLP | Tel : +44 (0)207 418 8900 |
James Steel | |
Oliver Jackson |
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a. | Name | Till Campe | ||||
2. | Reason for the notification | |||||
a. | Position/status | Non-Executive Director | ||||
b. | Initial notification /Amendment | Initial | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a. | Name | Immunodiagnostic Systems Holdings plc | ||||
b. | LEI | 213800HZMYTD4NGF4L78 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 2p each in Immunodiagnostic Systems Holdings plc GB00B01YZ052 | ||||
b. | Nature of the transaction | Purchase | ||||
c. | Price(s) and volume(s) |
| ||||
d. | Aggregated information · Aggregated volume · Price | N/A | ||||
e. | Date of the transaction | 2017-01-20 | ||||
f. | Place of the transaction | London Stock Exchange, AIM | ||||
IDS - Immunodiagnostic Systems Holdings plc published this content on 20 January 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 20 January 2017 16:29:04 UTC.
Original documenthttp://otp.investis.com/clients/uk/ids_plc/rns/regulatory-story.aspx?cid=31&newsid=838451
Public permalinkhttp://www.publicnow.com/view/7A4945A28854E1938908B19B09F9337B0A388831
